Why are children waiting so long for new meds?
COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
hiv
Chinese, US scientists identify bacterial secreted proteins that can inactivate coronavirus
This can provide a future avenue for the development of broad-spectrum antiviral drugs that might reduce the clinical burden…
GSK’s long-acting injection beats Truvada in HIV prevention trial
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection
HIV first-in-class pipeline sees high levels of innovation that targets drug resistance and latency…
There are 87 first-in-class products that act on a range of 50 molecular targets, which can broadly be classified as host or viral…
Gilead Sciences awards grants to address HIV challenges in India
Four Indian recipients out of 39 submissions to receive the grant
Gilead Sciences announced the recipients of its 2019 Gilead…
Gilead Sciences announces launch of Asia Pacific Rainbow Grants Program in India
This year’s grants program seeks to improve the quality of life of people living with HIV by focusing on three priority areas
HIV therapeutics market will crawl to $15.3 bn by 2023
The treatment landscape is expected to experience a paradigm shift towards integrase inhibitor drugs and single-tablet regimens
New amfAR awards accelerate research towards HIV cure
Renewal funding of $850,000 will go to a consortium of European researchers
Mobile application on HIV/AIDS launched
Mobile application will provide complete information on HIV, increase awareness and risk perception as well as prompt users to…
Cipla gets US FDA approval for Lopinavir and ritonavir oral pellets
These are used for the treatment of AIDS in infants and young children